[Implementing mindfulness based therapies as part of the comprehensive treatments in the Beer Sheba Mental Health Center].

In recent years, there has been a growing interest and popularity in mindfulness-based therapies. Theories and practices that, until lately, have been considered esoteric and practiced in private by only a few therapists, are now progressively becoming part of mainstream establishment therapies and are gaining greater interest and recognition. The therapies can be carried out either in an individual or in a group setting and most include formal mindful sitting practice, developing awareness, mindful movement, psycho-education and often include a cognitive component. Furthermore, these therapies are becoming increasingly validated by widespread research pointing to promising results in the treatment of various cLinicaL disorders including anxiety, depression and relapse prevention, personality disorders, attention disorders and psychotic disorders, in both an in-patient and out-patient setting. The aim of this overview is to describe the deveLopment that has taken place in the fast decades within the field of mindfulness-based therapies and to present the most up-to-date research in this area: to show which therapeutic interventions have been proven to be effective; the background of the ideas; and the relevance of these approaches to the mental health system in Israel.

Hyperacute renal failure as the initial presentation of systemic lupus erythematosus.

SLE nephritis is usually a slow process that may lead to renal failure many years after its first presentation. Success of different therapeutic modalities in preventing renal failure is therefore evaluated and compared only after many years of treatment. Lately, this conservative philosophy has been challenged with the acknowledgment of collapsing glomerulopathy (CG), a recent recognized clinical-pathological entity, characterized by rapidly progressive renal failure. Despite this ominous description we present an unusual case of a patient who presented with systemic lupus erythematosus (SLE) and clinical and pathological findings of CG, who completely remitted several weeks after commencing immunosuppressive therapy with intravenous cyclophosphamide and prednisolone.